Back to Dashboard

D7405C00001

ALLNCT06137118Last updated: 2/17/2026
Recruiting

Study Design

Study Drug

AZD0486

Mechanism of Action

anti-CD19/CD3

Sponsor

Unknown

Design

I/ II

Control Arm

-

Criteria

Inclusion Criteria

1.≥2 prior Tx 2. CD19(+) 3. PH(+)->至少兩線TKI failure or replase 4. PH(-)->至少兩線systemic therapy failure

Age: 1. ≥12 years 2. CD19+ Phase: I/ II

Exclusion Criteria

Enrollment

Progress0 / 3

Contact Information

Principal Investigator

Unknown

Study Nurse

吳軒綾

Contact Tel

3998